Private Capital Group’s Biodesix BDSX Stock Holding History

Private Capital Group’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40	Closed	-$1K	–	1901
2022 Q1	$1K	Buy	+40	New	+$2.61K	﹤0.01%	1901

Other funds holding BDSX

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Private Capital Group's BDSX Position: Q2 2022 in Review

Private Capital Group sold out of Biodesix (BDSX) in Q2 2022, closing a stake of 40 shares — an estimated $1K sold.

Private Capital Group first reported a position in BDSX in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 36 funds tracked by Wall St. Rank hold BDSX as of Q2 2022.

Private Capital Group reported no remaining Biodesix position as of Q2 2022 after selling out during the quarter.
Private Capital Group sold 40 Biodesix shares in Q2 2022, an estimated $1K.
Private Capital Group first reported a position in Biodesix in Q1 2022 and held it in 1 quarter.
Private Capital Group's Biodesix position peaked at $1K in Q1 2022.
36 funds tracked by Wall St. Rank held Biodesix as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.